Glutamate Carboxypeptidase 2 Market Growth, Size, Share, Industry Report and Forecast 2021-2027
The global glutamate carboxypeptidase 2 market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Glutamate Carboxypeptidase 2 is an enzyme that is encoded by the FOLH1 (folate hydrolase 1) gene in humans and is a class 2 membrane glycoprotein. It is used for the diagnosis and treatment of prostate cancer, and neurological disorder, among others. The major factor contributing to the growth of the market is the increasing prevalence of prostate cancer across the globe.
To Request a Sample of our Report on Glutamate
Carboxypeptidase 2 Market: https://www.omrglobal.com/request-sample/glutamate-carboxypeptidase-2-market
According to the American Cancer Society, in 2022, there
will be an estimated 268,490 new cases of prostate cancer with a mortality rate
of 34,500. Additionally, approximately 1 man in 8 is diagnosed with prostate
cancer during his lifetime and it is more likely to develop in older men and
non-Hispanic black men. Furthermore, approximately 6 cases in 10 are diagnosed
in men of age 65 years or older. However, it is rare in men under 40 and the
average age of men at diagnosis is about 66. Hence, the increasing prevalence
of prostate cancer is driving the demand for GCP 2 treatment, which in turn, is
driving the market growth. Furthermore, the market is growing due to new FDA
approvals. For instance, in September 2021, Martin Pomper, M.D., PhD, a
professor in the Johns Hopkins Medicine Department of Radiology and
Radiological Science, received the US Food and Drug Administration’s approval
for positron emission tomography (PET) imaging agent targeting the
prostate-specific membrane antigen (PSMA).
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Eisai Co Ltd, and Inovio
Pharmaceuticals Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Glutamate Carboxypeptidase 2 Market is Available @ https://www.omrglobal.com/industry-reports/glutamate-carboxypeptidase-2-market
Global Glutamate Carboxypeptidase 2 Market Report by
Segment
By Type
• INO-5150
• E-2072
• Others
By Application
• Prostate Cancer
• Neuropathic Pain
• Congnitive Impairment
• Glioblastoma Multiforme
• Others
Global Glutamate Carboxypeptidase 2 Market Report by
Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries
are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment